Education
About Us
Working with TipRanks
Follow Us
Rocket Pharmaceuticals (RCKT)
NASDAQ:RCKT
RESEARCH TOOLSreports
Rocket Pharmaceuticals (RCKT) Ownership Overview
34.67% Insiders
22.53% Mutual Funds
0.51% Other Institutional Investors
11.37% ETFs
30.92% Public Companies and Individual Investors
The ownership structure of Rocket Pharmaceuticals (RCKT) stock is a mix of institutional, retail, and individual investors. Approximately 34.41% of the company’s stock is owned by Institutional Investors, 34.67% is owned by Insiders, and 30.92% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 27, 2025 | Jonathan David Schwartz Chief Medical & Gene Therapy Officer | xxxxxxxxxxxxx | $223965 |
| Feb 25, 2025 | John Militello Vp Of Finance, Treasurer, Principal Accounting Officer | xxxxxxxxxxxxx | $28957 |
| Feb 25, 2025 | Gaurav Shah Ceo,director | xxxxxxxxxxxxx | $172486 |
| Feb 25, 2025 | Kinnari Patel President, Head Of R&d And Coo | xxxxxxxxxxxxx | $64305 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $313030 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1220283 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $4758800 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $8200931 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,157,605 | Insider | 17.08% | 190,110,124 | |
| 16,272,635 | Insider | 15.30% | 170,374,488 | |
| 6,490,225 | Institution | 6.10% | 67,952,656 | |
| 6,257,876 | Institution | 5.88% | 65,519,962 | |
| 4,622,076 | Institution | 4.35% | 48,393,136 | |
| 4,118,672 | Institution | 3.87% | 43,122,496 | |
| 3,420,574 | Institution | 3.22% | 35,813,410 | |
| 1,851,097 | Institution | 1.74% | 19,380,986 | |
| 1,195,221 | Insider | 1.12% | 12,513,964 | |
| 1,053,860 | Institution | 0.99% | 11,033,914 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,490,225 | Institution | 6.10% | 67,952,656 | |
| 4,622,076 | Institution | 4.35% | 48,393,136 | |
| 1,053,860 | Institution | 0.99% | 11,033,914 | |
| 1,044,279 | Institution | 0.98% | 10,933,601 | |
| 1,008,397 | Institution | 0.95% | 10,557,917 | |
| 770,691 | Institution | 0.72% | 8,069,135 | |
| 718,153 | Institution | 0.68% | 7,519,062 | |
| 717,463 | Institution | 0.67% | 7,511,838 | |
| 690,270 | Institution | 0.65% | 7,227,127 | |
| 580,600 | Institution | 0.55% | 6,078,882 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,621,765 | Institution | 2.47% | 32,955,586 | |
| 1,768,058 | Institution | 1.66% | 18,511,567 | |
| 1,672,911 | Institution | 1.57% | 16,929,859 | |
| 1,282,392 | Institution | 1.21% | 16,119,667 | |
| 1,063,115 | Institution | 1.00% | 13,363,356 | |
| 606,124 | Institution | 0.57% | 6,346,118 | |
| 600,791 | Institution | 0.56% | 7,551,943 | |
| 590,441 | Institution | 0.56% | 6,181,917 | |
| 405,231 | Institution | 0.38% | 4,100,938 | |
| 311,503 | Institution | 0.29% | 3,915,593 |
FAQ
Who Owns Rocket Pharmaceuticals (RCKT)?
According to the latest TipRanks data, approximately 0.51% of the company's stock is held by institutional investors, 34.67% is held by insiders, and 30.92% is held by retail investors.
What percentage of Rocket Pharmaceuticals (RCKT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.51% of Rocket Pharmaceuticals (RCKT) stock is held by institutional investors.
What percentage of Rocket Pharmaceuticals (RCKT) stock is held by retail investors?
According to the latest TipRanks data, approximately 30.92% of Rocket Pharmaceuticals (RCKT) stock is held by retail investors.
Who owns the most shares of Rocket Pharmaceuticals (RCKT)?
RTW INVESTMENTS, LP owns the most shares of Rocket Pharmaceuticals (RCKT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.